NOVARTIS PHARMA AG;MASSACHUSETTS INSTITUTE OF TECHNOLOGY
发明人:
Allan Stuart Myerson,Xiaochuan Yang,Marcus O'Mahony,Markus Krumme,Norbert Rasenack,Leia Dwyer,Marcus OMahony
申请号：
US15301221
公开号：
US20180185286A1
申请日:
2015.03.31
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Materials containing pharmaceutically active species in solid (e.g., crystal) form, and related methods, are provided, allowing for improved stability, solubility, bioavailability, and/or dissolution rates for pharmaceutically active species having poor aqueous solubility.
